Beam Therapeutics Inc. (BEAM)

Beam Therapeutics Revenue

Beam Therapeutics had revenue of $31.74M in the quarter ending March 31, 2026, with 324.87% growth. This brings the company's revenue in the last twelve months to $164.01M, up 157.97% year-over-year. In the year 2025, Beam Therapeutics had annual revenue of $139.74M with 120.01% growth.

• Revenue (ttm): $164.01M
• Revenue Growth: +157.97%
• P/S Ratio: 21.13
• Revenue / Employee: $314,197
• Employees: 522
• Market Cap: 3.46B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	139.74M	76.23M	120.01%
Dec 31, 2024	63.52M	-314.19M	-83.18%
Dec 31, 2023	377.71M	316.79M	520.01%
Dec 31, 2022	60.92M	9.08M	17.51%
Dec 31, 2021	51.84M	51.82M	215,916.67%
Dec 31, 2020	24.00K	6.00K	33.33%
Dec 31, 2019	18.00K	-	-
Dec 31, 2018	-	-	-

Data Source: Fiscal.ai Last updated: May 7, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 26, 2026

Data Sources Report a data error